-
Commercialization Education -
FFMI fastPACE -
Frankel Cardiovascular Center Innovation Program -
Rogel Cancer Center Innovation Program -
Global Health Commercialization Competition -
Biomedical Innovation 101 -
Certificate in Biomedical Innovation & Entrepreneurship -
Fast Forward Medical Innovation Fellowship Program -
Biotech Career Development Program -
Drug Discovery & Development Course -
Innovation Studio -
Oncology Drug Discovery & Development (3D) Workshop -
FFMI fastPACE Train-the-Trainer -
Industry-Ready Webinar Series -
Intellectual Property in the Academic Setting -
Drug Discovery and Development Course -
Medical Device Regulation -
Idea to Impact Webinar Series -
6 Tips for Customer Discovery -
Interacting with Industry -
Ask the Experts: A Biomedical Innovation Forum
-
-
Business Development -
Michigan Biomedical Venture Fund -
Innovation Portfolio -
Meet the Team
Michigan Biomedical Venture Fund
Fast Forward Medical Innovation
We create a critical pipeline between research and the biomedical innovation life cycle.
The Michigan Biomedical Venture Fund (MBVF) invests in and supports life science startup companies with U-M licensed intellectual property – including therapeutics, medical devices, diagnostics, and health IT. The MBVF is a collaborative effort between the U-M Medical School’s Fast Forward Medical Innovation (FFMI) program and the U-M College of Engineering’s Center for Entrepreneurship (CFE).
Founded based on an initial gift from the Monroe-Brown Foundation, MBVF makes seed-stage equity investments in U-M life science startup companies. This evergreen fund serves to drive the university’s world-class leadership by creating a critical pipeline between research and the biomedical innovation life cycle, resulting in broad clinical and economic impact through startups.
Michigan Biomedical Venture Fund Team
John Seamans, MSE
Nimisha Nandankar, MS
Michigan Biomedical Venture Fund
OUR IMPACT
"FFMI's fastPACE commercialization course helped us learn a lot of the basics and develop our first business model canvas. Several years later, the Michigan Biomedical Venture Fund provided investment and valuable connections, including introductions to potential collaborators. We are now exploring optimizing the timing of immunotherapy and other conditions with U-M researchers."
Questions?
Contact Us
Fast Forward Medical Innovation
University of Michigan Medical School
Ann Arbor, Michigan
